AbbVie partners with Valkai to deploy AI across clinical development
ABBV•AbbVie partnered with Valkai to deploy AI tools in targeted areas of clinical development, aiming to improve research efficiency, speed insight generation and reduce drug development timelines.
1. AI in clinical research
AbbVie entered a partnership with Valkai to deploy AI tools across targeted areas of clinical development. The collaboration aims to improve efficiency in clinical research, speed insight generation and reduce drug development timelines; it expands AbbVie’s use of AI across R&D as clinical data volumes and complexity increase.
